Media
Filters:
September 7, 2023
GaoTeng - Is China still investable?
GaoTeng is an asset management company with the strategic backing of Tencent Holdings and Hillhouse Capital Group. It has a multi-award-winning Greater China focus equity long/short strategy that aims to deliver strong risk-adjusted returns throughout the market cycles.The question of “Is China still investable?” has been heatedly debated among global…
August 23, 2023
Macro Views with Thanos Papasavvas, CFA
Thanos is the Founder & CIO of ABP Invest, a research boutique established in 2015 to provide strategic outlook and analysis on geopolitics, economics, markets and FX. The team seems to have made prescient calls in the past including calling for higher inflation from June 2020 and the subsequent hiking cycle in US rates. Thanos maintains high…
March 7, 2022
Volatility is your friend
Author, Hannah Marcheselli Volatility is top of mind for investors against today’s market backdrop, particularly with inflation and interest rates on the rise. By understanding where volatility can fit within your portfolio, you can learn not to fear it, but to embrace it, says Pierre de Saab, Partner and Head of Asset Management at Dominicé, the…
March 4, 2021
The transformative power of technology in alternative investments
This blog is the first in a series exploring topics from investments and strategy to decision support and data management. “57% of Allocators to Hedge Funds are planning to invest in data management in the next 12 months” 2021 Global Investment Survey on Emerging Technologies, Allocator. Global financial markets have arrived at a watershed moment, with…
February 26, 2021
CNBC Interview with the CEO and Founder at Allocator
Watch the exclusive CNBC interview about the 2020 Hedge Fund Performance and 2021 Top Performing Funds Since 2018, the Investors Choice Awards have gone digital. Competition is fierce, with more funds than ever before being considered in each peer group. More institutional investors are participating in the judging process than ever before, and all funds…
December 9, 2020
Assessing opportunities in Healthcare: Q&A with Dr Bianca Ogden
2020 has proven to be a volatile year for investment managers due to COVID-19. The emergence of new biotech and healthcare companies have tested sector specialist strategies even more than before. On the 21st of October 2020, we had the privilege of hosting Dr Bianca Ogden, Virologist Portfolio Manager at Platinum Asset Management to share their approach to…